24.9 C
New York
Tuesday, June 6, 2023

Value Investing Philosophy And Core Laboratories N.V. (NYSE: CLB)?

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. After-hours trades for Core Laboratories N.V. (CLB) shows that investor sentiment remained same, with the stock’s consolidated last price remained same to $22.03. The Core Laboratories N.V. has recorded 3,399 volume in the after hours trading session. Recently, Yahoo Finance discussed the stock, revealing that CORE LAB REPORTS FIRST QUARTER 2023 RESULTS:.

Unlock the Hottest Top 10 Penny Stocks Today! Discover Now

Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.

Gain Access to Top 10 Penny Stocks Now!.


Stocks Info

CLB belongs to the Energy sector of the NYSE while operating in the Oil & Gas Equipment & Services industry. At the end of the last regular session, the stock closed at $22.03 and fluctuated between $22.69 as its day high and $21.83 as its day low. The current market capitalization of Core Laboratories N.V. is $1.03B. A total of 0.61 million shares were traded on the day, compared to an average of 356.93K shares.

Investors also take into account insider trades in predicting how the stock will perform in the future. During the recent three months, CLB has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 10 BUYs and 12 SELLs from insiders. Insiders purchased 135,362 shares during that period but sold 63,877.


Paying dividends generates immediate cash flow for investors and indicates a positive outlook for the company. Core Laboratories N.V. pays an annual dividend of $0.04, resulting in a dividend yield of 0.18%, and it has a price to earnings (P/E) ratio of 43.62. CLB’s most recent ex-dividend date was 5/5/2023 when it declared a $0.01 quarterly dividend that was paid in cash on 5/30/2023. Previously, the company paid the dividend on 3/6/2023 with an ex-dividend date of 2/10/2023. The CLB stock dividend was $0.01 per share in cash.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. According to analysts who have offered 12-month price targets for CLB in the last 3 months, the mean price target is $22.81 with high estimates of $32.00 and low estimates of $18.00. In terms of 52-week highs and lows, CLB has a high of $31.42 and a low of $13.19.

As of this writing, CLB has an earnings estimate of $0.21 per share for the current quarter. EPS was calculated based on a consensus of 7 estimates, with a high estimate of $0.22 per share and a lower estimate of $0.19.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. CLB’s latest balance sheet shows that the firm has $17.70M in Cash & Short Term Investments as of fiscal 2021. There were $250.26M in debt and $90.78M in liabilities at the time. Its Book Value Per Share was $4.19, while its Total Shareholder’s Equity was $161.00M.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 9 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CLB is Overweight with a score of 2.80. A total of 0 analysts rated the stock as Buy while 1 rated it as Overweight while 6 rated it as Hold. Among the other participants, 1 thought the stock was Underweight and 1 thought it should be Sold.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles